Notice: Prescription Drug List (PDL): Sotrovimab (COVID-19)
The purpose of this Notice of Amendment is to notify about the addition of sotrovimab to the Prescription Drug List (PDL) for human and veterinary use.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2023-09-30
Data overview
- Formats
- HTML
- File languages
- English, French